Your browser doesn't support javascript.
loading
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT).
Maggadóttir, Sólrún Melkorka; Kvalheim, Gunnar; Wernhoff, Patrik; Sæbøe-Larssen, Stein; Revheim, Mona-Elisabeth; Josefsen, Dag; Wälchli, Sébastien; Helland, Åslaug; Inderberg, Else Marit.
Affiliation
  • Maggadóttir SM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
  • Kvalheim G; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
  • Wernhoff P; Department of Medical Genetics, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Sæbøe-Larssen S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
  • Revheim ME; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Josefsen D; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
  • Wälchli S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
  • Helland Å; Department of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Inderberg EM; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Front Oncol ; 12: 1031232, 2022.
Article de En | MEDLINE | ID: mdl-36439452
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Aspects: Patient_preference Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Aspects: Patient_preference Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Suisse